October 30, 2023
At CTAD 2023 (Clinical Trials on Alzheimer’s Disease; Boston, USA, October 24-27), Professor Shimokawa presented the protocol of the LIPUS-Brain pivotal study (LIPUS-AD).
At CTAD 2023 (Clinical Trials on Alzheimer’s Disease; Boston, USA, October 24-27), Professor Shimokawa, Founder and Chairman of the Company, presented the protocol of the LIPUS-Brain pilot study (LIPUS-AD). The presentation was given by Prof. Shimokawa, Founder and Chairman of the Board of Directors of the Company.
【Title of the presentation.】 Pivotal Trial of Low-intensity Pulsed Ultrasound Therapy for Early Stage of Alzheimer’s Disease (LIPUS-AD) –Rationale and Design- （Presentation Poster）
Presented in the New Therapies and Clinical Trials section. This was the only presentation on the development of medical devices for Alzheimer’s disease at the conference.
【View the presentation】
【本件に関するお問い合わせ】 サウンドウェーブイノベーション株式会社 広報担当 mail：info@sw-innovation.com